Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 45 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
TRISPORT PHARMA from Beernem, company number BE0433713130, closed financial year 2025 with a result of € 21,663 after tax. For that financial year TRISPORT PHARMA recorded a gross margin of € 17,511 and equity of € 11,484. Compared with financial year 2024, the result moved from € -12,553 to € 21,663. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 11,484
▲ € 21,663 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 21,663
▲ still € 12,553 loss in 2024
Profit after tax over the fiscal year.
€ 13,302
▼ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -36,856.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 770
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -21,819 | € -10,155 | € -6,534 | € 17,511 | ▲ € 24,045 |
| Profit after taxes | € -22,306 | € -12,064 | € -12,553 | € 21,663 | ▲ € 34,216 |
| Equity | € 14,438 | € 2,374 | € -10,179 | € 11,484 | ▲ € 21,663 |
| Total debts | € 80,364 | € 86,127 | € 91,823 | € 74,848 | ▼ 18% |
| Cash | € 13,096 | € 8,174 | € 26,195 | € 13,302 | ▼ 49% |
| Retained profit | € -33,901 | € -45,965 | € -58,518 | € -36,856 | ▲ € 21,663 |
| Balance sheet total | € 94,802 | € 88,501 | € 81,643 | € 86,332 | ▲ 6% |
Key figures of TRISPORT PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to TRISPORT PHARMA?
What happened at TRISPORT PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 21,663. filed late Source: NBB ↗
- New establishment in Beernem. KBO
- Michèle Boutlegier became a director. NBB
- Kurt Vancoppenolle became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 22,306 loss in 2022 to € 21,663 profit in 2025.
Best year ever: 2025, with € 21,663 profit.
Management
Behind TRISPORT PHARMA are Michèle Boutlegier and Kurt Vancoppenolle. The same people are also behind Bloemeghem. Kurt Vancoppenolle is also behind TECHNICAL EQUIPMENT SUPPLIES and ROCA.
Directors
According to the 2025 annual accounts
since 2013
since 2013
Establishments
Establishment units
Physical locations of this company
Gevaerts-Noord 4
8730 Beernem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0433.713.130
- VAT number
- BE 0433.713.130
- Registered office
- Gevaerts-Noord 4, 8730 Beernem
- Names & denominations
- TRISPORT PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 March 1988
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Vervaardiging van gehomogeniseerde voedingspreparaten en dieetvoeding